New Study Highlights Vitamin D’s Role in Cardiometabolic Health

A recent systematic review and meta-analysis published in Engineering reveals that vitamin D supplementation significantly enhances cardiometabolic health, particularly among non-Western populations, the elderly, and individuals with low baseline vitamin D levels, SciTech Daily reported.

Analyzing 99 randomized controlled trials involving 17,656 participants, researchers found that a median dose of 3,320 International Units (IU) per day led to notable reductions in systolic and diastolic blood pressure, total cholesterol, fasting blood glucose, hemoglobin A1C, and insulin levels.

The study emphasizes the necessity for personalized vitamin D interventions, tailored to individual factors such as age, ethnocultural background, and body mass index (BMI). It suggests that longer intervention durations and higher doses could optimize health outcomes. The findings underscore the potential for improved public health strategies through targeted vitamin D supplementation, aiming to reduce the prevalence of cardiometabolic diseases and enhance preventive medicine. Future research is encouraged to explore the mechanisms and long-term effects of high-dose vitamin D supplementation.